Print
Carlos Pato will be the first executive chair of psychiatry at Rutgers Biomedical and Health Sciences and Michele Pato will become the inaugural director of the new Rutgers Center for Genomics of Psychiatric Health and Addiction.
Carlos Pato and Michele Pato to Oversee Behavioral Health, Addictions and Genomic Psychiatry Research
Rutgers has selected two distinguished psychiatrists – husband and wife Carlos N. Pato and Michele T. Pato – to oversee behavioral health, addictions and genomic psychiatry research, a rapidly growing field in psychiatric medicine that investigates the genetic connections to mental health.
Carlos Pato will be the first executive chair of psychiatry at Rutgers Biomedical and Health Sciences (RBHS) and Michele Pato, the director of SUNY Downstate’s Institute for Genomic Health, will become the inaugural director of the new Rutgers Center for Genomics of Psychiatric Health and Addiction (RCPHA) and will join her husband as professor of psychiatry at Rutgers Robert Wood Johnson Medical School and Rutgers New Jersey Medical School.